Atlas Trials

CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML

Clinical trial NCT06763666 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06763666
Sponsor
Nanfang Hospital, Southern Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Relapsed/Refractory AML
Start date
2025-02-01
Primary completion
2025-06-01
Enrollment
172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.